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Background & objectives: HLA-DR2 has been shown to be associated with the susceptibility to 
pulmonary tuberculosis and altered antibody and lymphocyte response in pulmonary tuberculosis. I n  
the present study, the influence of DR2 subtypes on antibody titre and lymphocyte response ,to 
Mycobacterium tuberculosis culture filtrate antigens (10 µg/ml) was studied in 22 patients with active 
pulmonary TB (ATB), 50 inactive (cured) TB (ITB) patients and 36 healthy control subjects. 
Methods. HLA-DR2 gene was amplified by polymerase chain reaction (PCR) and  dot-blotted. 
Genotyping of DRBl*1501, *1502, *1503, *1601 and *1602 was carried out using sequence specific 
oligonucleotide probes (SSOPs) and detected by chemiluminescence method. Antibody titre as well 
as  lymphocyte response to M.tuberculosis antigens were measured by enzyme linked immunosorbent 
assay (ELISA) and  lymphocyte transformation test (LTT) respectively. 
Results: The allele frequency of DRB1*15Ol was significantly increased in pulmonary tuberculosis 
patients as  compared to controls (P<0.05). No marked difference in the antibody titre and lymphocyte 
response to  M. tuberculosis antigens was observed between the DRBl *1501, *1502 and *1503 positive 
o r  negative controls, ATB and ITB patients. DRBl *1501 and *1502 positive as well as  negative ATB 
patients showed a higher antibody titre as compared to controls and ITB patients. ITB patients with 
*1502 showed a higher lymphocyte response as  compared to *1502 positive controls (P<0.001) and 
ATB patients (P<0.05). Similarly, an increased lymphocyte response was observed in *1501, and 
*I503 negative ITB patients compared to *1501 and *1503 negative controls and ATB patients. 
Interpretation & conclusion: The present study revealed that  DRBl *1501 may be associated either 
alone o r  with other DR2 alleles, with the susceptibility to pulmonary tuberculosis. None of the DR2 
alleles influenced the antibody and lymphocyte response to M tuberculosis culture filtrate antigens. 
This suggested that  HLA-DR2 gene/gene products as a whole may influence the immune response i n  
pulmonary tuberculosis. 
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Genetic susceptibility in infectious diseases, 
especially in mycobacterial diseases is well 
documented 1-5.  The innate/genetic immunity is 
thought to play a key role in determining the direction 
of the adaptive immune response, especially in 
chronic infectious diseases in humans6. 
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Studies on the host genetics in pulmonary 
tuberculosis by various groups in India, including ours 
have revealed the association of HLA-DR2 with the 
susceptibility to pulmonary tuberculois2-4. With the 
advances in molecular biological techniques, the 
subtypes of HLA-DR2 have been documented7-10. 
These studies have shown that the molecular 
subtypes HLA-DRBI *1501 either alone or in 
combination with *1502 are associated with the 
susceptibility to pulmonary tuberculosis in India9,10 
Our earlier study revealed that HLA-DR2 is 
associated with a trend towards an augmented 
humoral immune response to antigens of 
Mycobacterium tuberculosis11. Moreover, HLA- 
DR2 has been shown to be associated with a low 
spontaneous lymphocyte response and a high 
responder status to M. tuberculosis antigens11 .  The 
influence of the HLA-DR2 subtypes on humoral and 
cell mediated immune response has not been studied 
in normal subjects, active tuberculosis patients and 
cured tuberculosis patients in a comprehensive 
manner. The present study was carried out to find 
out the HLA-DR2 subtype/subtypes that are 
associated with the susceptibility to pulmonary 
tuberculosis, as well as the influence of these 
subtypes on the antibody titre (humoral immune 
response) and lymphocyte response (an in vitro 
correlate of cell-mediated immune response) to 
culture filtrate antigens of M. tuberculosis in 
patients with active disease and cured patients 
(inactive stage of the disease). 
Material & Methods 
Study subjects: Subjects included were 72 pulmonary 
tuberculosis patients (PTB) (22 active and 50 
inactive PTB) and 36 healthy controls. Among the 
active TB patients, 21 were males and 1 was a 
female, aged 37.4±2.6 yr and 25 yr respectively. 
Among the inactive TB patients, 38 were males and 
12 were females aged 38.5±1.3 yr and 39.5±2.8 yr 
respectively. Of the controls, 15 were males and 21 
were females, aged 36.4±2.0 yr and 36.7±1.7 yr 
respectively. 
(i) Active pulmonary tuberculosis patients 
(ATB)-Patients attending the clinic at the 
Tuberculosis Research Centre (TRC), Chennai, with 
respiratory symptoms and radiographic abnormalities 
suggestive of pulmonary TB were studied. These 
patients (22) were sputum positive for M .  
tuberculosis by smear and culture. Blood was 
drawn before starting anti-tuberculous treatment. 
(ii) Inactive tuberculosis patients (ITB) (cured 
patients)-These patients (50) were selected from 
among the subjects of an earlier chemotherapy study. 
Patients classified as suffering from active 
pulmonary tuberculosis had 
course chemotherapy of 6 t 
had been followed for five 
the time of blood sample C I  
patients were in the quiescc 
(iii) Controls-The con 
contacts (16) (spouses who 
the patients before, during 
period of 10-15 yr) and staff (20) working at TRC 
for more than 3 years. All the family contacts and 
other control subjects were clinically normal at the 
time of blood sample collection. The patients and the 
spouses were not consanguineous with each other. 
The other control subjects were not related to any of 
the patients. 
The patients and th 
selected and belonged 
They were Tamil speaki 
to different communities 
Chennai. 
For genotype analys 
were included as a sin 
irrespective of the st 
presented with viz., acti 
the immune functions 
were considered separat 
This study was condu 
Processing of blood 
heparinised venous bloc 
individual and subjectec 
gradient centrifugation. The upper layer of plasma 
was separated and used in ELISA for measuring the 
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antibody titre. Peripheral blood mononuclear cells 
and used for HLA-DR serological typing, lymphocyte 
transformation test (LTT)4,11 and DNA extraction. 
Extraction of human genomic DNA: Genomic DNA 
was extracted from PBMC using a saltinig out 
procedure as described elsewhere12. 
(vi) DRB 7003 - DRB1*1602:5'- Biot - GAC CTC 
All the probes were purchased commercially 
(PBMC) were collected and separated into portions CTG GAA GAC AGG-3' 
(Gibco-BRL, Grand Island, NY, USA). 
Dot blotting and oligonucleotide hybridisation: 
The PCR product (10 µl) was denatured by adding 
90 µl of freshly prepared denaturing solution [9.9 ml 
of Tris EDTA (ethylene diamine tetraacetic acid), 
of 6M NaOH]. The mixture was placed on ice during 
acetate was added to the denaturing mixture to stop 
Genotyping Of HLA-DR2 subtypes: DNA typing of (pH 8.0), 0.66 ml of 0.5M EDTA (pH 8.0), 0.88 ml 
DRB1 *1503, *1601 and *1602 HLA- 
reaction (PCR) and sequence specific 
DR2 subtypes was carried out using polymerase denaturation for 10 min, and 100 µl of 2M ammonium 
oligonucleotide Probes The second of the reaction. The DNA was dot-blotted on Nytran 
the DRB gene was using DR2 group membrane (Boehringer Mannheim GmbH, 
specific primers (DRB1-DR2) in a Programmable Mannheim, Germany) using a dot-blot apparatus 
(Gibco-BRL, Grand Island, NY, USA). The 
(UV) cross-linked in a UV cross-linker (Bio-Rad, 
Hercules, CA, USA) at 250 mJ and stored at -20oC 
thermalcycler (MJ Research Inc., Watertown, MA, 
CAG CCT AAG AGG-3'; and (ii) 5'-CCG CTG 
USA). The primers used were (i) 5'-TTC CTG TGG membrane was baked for 2 h at 80°C or ultra-violet 
CAC TGT GAA GCT CT-3'. 
until use. Twenty five microlitres of the PCR reaction 
mixture containing 100ng of genomic DNA, 200 µM 
of dNTPs (Gibco-BRL, Grand Island, NY, USA) 20 
pmol of each primer (Genei, Bangalore, India), 1 unit 
of Taq DNA polymerase and buffer (Genei, 
Bangalore, India) was used for PCR amplification 
using the following cycling conditions: 96°C for 30 
sec (denaturation), 61°C for 30 sec (annealing) and 
72°C for 60 sec (extension) for 30 cycles. The PCR 
product (265 base pair) was checked in a 0.8 per 
cent agarose (Gibco-BRL, Grand Island, NY, USA) 
gel containing 0.1 per cent ethidium bromide. 
Biotinylated SSOPs: All the probes were biotinylated 
at the 5' end 
(i) DRB8603-DRB1*1501:5'-Biot-AAC TAC 
(ii) DRB8601 -DRB1 * 1502+* 1601+* 1602:5'-Biot- 
(iii) DRB 7011-DRBl* 1501+*1502:5' Biot-GAC 
(iv) DRB2814-DRB1*1503:5'-Biot-CTG GAC 
(v )  DRB7002-DRBl* 1601:5'-Biot-GAC TTC CTG 
GGG GTT GTG GAG-3' 
AAG TAC GGG GTT GGT GAG-3' 
ATC CTG GAG CAG GCG - 3' 
AGA CAC TTC TAT AA-3' 
GAA GAC AGG-3' 
Hybridisation and stringency wash: The membrane 
was blocked with 10 ml blocking solution [4X sodium 
chloride, sodium phosphate, EDTA (SSPE), 1 per 
cent casein hydrolysate (SRL, Mumbai. India) and 
0.1 per cent lauryl sarcosine hydrolysate (SRL, 
Mumbai, India)] in a hybridisation oven (Hybaid Ltd., 
UK) at room temperature. Prehybridisation was done 
with 10 ml of hybridisation solution [3M T'MAC 
(tetramethylammonium chloride; SRL, Mumbai, 
India), 50 m M Tris (pH8.0), 0.1 per cent SDS 
(sodium dodecyl sulphate), 2m M EDTA] for 45 min 
at 55°C in the hybridisation oven. 
Biotinylated SSOPs (5 pmol/ml) were added to 
the hybridisation solution and hybridisation was 
carried out overnight at 55°C. Membranes were then 
washed with 25 ml of wash buffer (2X SSPE, 0.1% 
SDS) at room temperature and stringency wash step 
was carried out with 10 ml of TMAC for 15 min at 
various temperatures as described earlier9 ( DRB 
8603: 62°C; DRB 8601: 62°C; DRB 701 1 : 62oC; 
DRB 2814: 63°C; DRB7002: 62.5oC and DRB 7003: 
61.5oC). 
After stringency wash, the membrane was washed 
in wash buffer. The washed membrane was blocked 
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with 20 ml of blocking solution (NaCl 125 m M, 
NaH2PO4 17 m M, Na2HPO4, 8 m M, SDS 173 mM) 
for 15 min at room temperature. The signal was 
detected using Phototope Detection Kit 6K (New 
England Biolabs Inc, Beverly, USA). Blocking 
solution containing streptavidin (1 µg/ml) was added 
to the membrane (50-60 µl/cm2) and incubated at 
room temperature for 20 min. The membrane was 
washed two times, 10 min each in wash solution-I 
(1 : 10 diluted blocking solution, 0.5 ml/cm2) at room 
temperature. 
This was followed by biotinylated alkaline 
phosphatase (0.5 µg/ml in blocking solution, 50 µl 
solution per cm2 membrane) incubation for 20 min at 
room temperature. The membrane was washed twice 
in 20 ml of wash solution-I1 [Tris-HC1 10 mM (pH 
9 . 5 ) ,  NaCl 10 mM, MgCl2 lm M] and drained. The 
membrane was treated with Lumigen-PPD substrate 
for 5-7 min. The membrane was kept wet in cling 
film and incubated at room temperature for 15 min. 
The chemiluminescent signal was detected on X-ray 
film after exposing the membrane for 15 and 30 min. 
' 
The membrane was stored until further use, at 
-20oC in a wet condition to ensure that it did not dry, 
as drying of the membrane leads to irreversible probe 
and DNA hybridisation. 
Stripping: The membranes were washed with 20 ml 
of stripping buffer-1 [20m M EDTA and 2X sodium 
chloride, sodium citrate (SSC)] for 30 min at 65°C. 
The second wash was done with 20 ml of stripping 
buffer-I1 (2X SSC and 0.1% SDS) for 15 min at 
room temperature. The membranes were then 
washed in stripping buffer-I11 (0.2 M NaOH, 0.1% 
SDS) at 37oC for 30 min. The stripped membranes 
were reprobed with the other probes. 
Five microgram per ml of M. tuberculosis 
H37Rv culture filtrate antigen was used in ELISA to 
measure the IgG antibody titre in plasma samples11,13 
and 10 µg/ml concentration of antigen was used in 
LTT to stimulate the lymphocyte culture11,13. The 
results of these experiments were compared with 
the HLA-DR2 subtypes. 
Statistical analysis: The frequencies of HLA-DR2 
subtypes were determined using direct allelic count. 
The significance was analysed using x2 test (Statcalc 
program, Epi Info, Version-5; USD; Stone Mountain, 
GA, USA). The results of antibody titre and 
lymphocyte response are expressed as mean ± 
standard error (SE) and the significance was 
assessed using Student's ' t '  test. Multiple 
comparison with analysis of variance (ANOVA) was 
done using Microsoft Excel, version 6.0 (Microsoft 
Corporation, Seattle, WA, USA). 
Results 
No marked difference in the antibody titre was 
observed between DR2 subtypes * 1501, * 1502 and 
* 1503 positive and negative control subjects, ATB 
and ITB patients. However, a decreased antibody 
titre was seen in *1503 positive ATB patients than 
*1503 negative patients. An increased antibody titre 
to M. tuberculosis culture filtrate antigens was seen 
in DRB1 * 1501 and * 1502 positive or negative ATB 
patients when compared to *1501 and *1502 positive 
or negative control subjects as well as ITB patients 
(Fig. 1) (Control vs ATB-* 1502 positive-P<0.01 ; 
*1503 negative-P<0.02; ATB vs ITB-*1501 and 
*1502 positive and *1503 negative - P<0.05, other 
comparisons were not significant). Further analysis 
using ANOVA between antibody titres of controls ,  
ATB patients and ITB patients was significant 
(P<0.001). However, comparisons of the three 
subtypes (DRB1 *1501, *1502 & *1503) within the 
three categories of study subjects were not 
significant. 
A significantly increased allele frequency of 
DRB1- * 150 1 was seen in pulmonary TB patients as 
compared to control subjects (P<0.05) (Table). 
However, the corrected P value for the number of 
DR2 alleles studied was not significant (Pc>0.05). A 
decreased frequency of alleles *1502 and *1503 was 
observed in patients when compared to control 
subjects. However, this difference was not 
significant. The frequencies of *1601 and * 1602 
were less or almost nil when compared to *150l .  
*1502 and *1503 in both controls and patients 
(Table). 
No difference in the lymphocyte response to 
M. tuberculosis culture filtrate antigens was 
observed between *1501, *1502 and *1503 positive 
and negative control subjects, ATB and ITB patients. 
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Fig. 1. Comparison of antibody titre to M. tuberculosis H37 Rv culture filtrate antigens in  subjects positive for various 
HLA-DR2 alleles among controls, ATB and ITB patients. Control vs ATB - *I502 - P<0.01; ATB vs ITB - *I501 - 
P < 0 . 0 5 ,  *I502 - P<0.05. Numbers in parentheses represent the number of subjects studied in each group. 
Table. Allele frequency of HLA-DR2 subtypes in pulmonary TB patients and control subjects 
HLA-DR2 subtype Allele frequency (%) 
Control (N=36) TB (N=72*) 
n % n % 
1501 11 30.5† 41 53.2† 
1502 19 52.8 27 35.1 
1503 6 16.7 7 9.1 
160l 0 0 0 0 
I 0 2 2.6 
n ,  n o .  o f  subjects positive for 
genotypes were 1502/1503, 1501/1502, 1502/1602, 1502/1502 and 150211503; †Odds ratio - 2.6; P < 0 . 0 5 ;  Pc >0.05 
allele; N ,  total number of subjects studied; * Five patients were homozygous for DR2 and their 
An increased lymphocyte response was seen in ITB 
patients with *1501 and *1502 positive and negative 
subjects (as well as *1503 negative ITB patients) 
when compared to control subjects and ATB 
patients. A significantly increased antigen induced 
lymphocyte response was seen in ITB patients with 
*1502 as compared to *1502 positive control subjects 
(P<O.OOl)  as well as ATB patients with *1502 allele 
(P<0.05). Similarly, *1501 negative and *1503 
negative ITB patients showed a higher lymphocyte 
response than *1501 and *1503 negative control 
subjects and ATB patients (control vs ITB- * 1501 
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negative - P<0.05;  control vs ITB *1503 negative - 
P<0.008; ATB vs ITB - *1501 negative - P<0.02; 
ATB vs ITB- *1503 negative - P<0.01) (Fig.2). 
Multiple comparisons with ANOVA showed a 
significantly increased lymphocyte response in ITB 
patients than *1501 negative control subjects and 
*1501 negative ATB patients (P<0.001). 
Discussion 
In the present study an increased allele frequency 
of DRB 1 *1501 was seen in pulmonary tuberculosis 
patients when compared to control subjects. Studies 
carried out in north Indian9 and south Indian10 
patients with pulmonary tuberculosis, revealed the 
association of HLA-DRBl *1501 and *1502, and 
HLA-DRB1 *1501 with the susceptibility to 
pulmonary tuberculosis. Our study also reveals the 
association of DRB1 *1501 with the susceptibility to 
pulmonary tuberculosis in south India. This suggests 
that allele DRBl *1501 may either alone or in 
combination with other DR2 alleles be associated 
50 
x 
w 40 
I 
n 
 
5 30 
5 
20 
F= cn 
10 
0 
with the susceptibility to tuberculosis in our south 
Indian population. 
High tuberculin response has been shown in 
individuals with HLA-DR1514. Further, an increase 
in the PPD induced lymphoproliferative response has 
been shown in DRBl *1501 PTB patients, when 
compared with *1502  patient15. Our earlier studies 
revealed that HLA-DR2 is associated with a trend 
towards an increased antibody titre to 
M. tuberculosis culture filtrate antigens in ATB 
patients", suggesting that HLA-DR2 as a whole or 
its subtypes may be associated with augmented 
antibody response during active stage of the disease 
as well as persistence of antibody titre to M .  
tuberculosis antigens. However, in the present study 
the DR2 alleles (subtypes) did not influence the 
antibody as well as lymphocyte response to 
M. tuberculosis antigens independently. This 
suggests that HLA-DR2 as a whole may Influence 
the immunity to tuberculosis. 
0 ALLELE POSITIVE 
a ALLELE NEGATIVE 
(') T 
1501 1502 1503 1501 1502 1503 1501 1502 1503 
CONTROLS ATB ITB 
HLA-DR2 SUBTYPES 
Fig. 2. Comparison of proliferative responses against M. tuberculosis H37Rv culture filtrate antigens among the controls, 
ATB and ITB patients positive for the different HLA-DR2 alleles. Controls vs ITB - *I502 - P<0.01; ATB vs IT'B - 
*1502 - P<0.05. Numbers studied in each group are represented in parentheses. 
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Our earlier studies also revealed an inverse 
correlation between antibody titre, spontaneous 
lymphoproliferative and antigen induced lymphocyte 
response in HLA-DR2 positive active TB patients11. 
In the present study also, irrespective of the disease 
status an inverse correlation between antibody titre 
and antigen induced lymphocyte response was 
observed with various DR2 alleles. This may be due 
to a shift from an early, predominantly Th1 type of 
response to a Th2 type of response in active 
pulmonary tuberculosis and a reversal of Th2 type 
of response to Thl  type of response in cured 
patients. 
Moreover, an increased lymphocyte response to 
M. tuberculosis antigens was seen in DRBl *1501, 
*1502 and *1503 positive as well as negative ITB 
patients as compared to ATB patients and control 
subjects, suggesting that ITB patients may regain 
the immune status and retain a strong memory T cell 
response (irrespective of whether they are positive 
or negative for the allele) as well as altered Thl and 
Th2 type of response to M .  tuberculosis. 
Irrespective of HLA-DR status, (DR2 positive or 
DR2 negative) altered level of cytokines released by 
different subsets of T helper cells and/or other 
factors that are released by the monocytes and/or 
lymphocytes during the active stage of the disease 
may be responsible for the low lymphocyte response 
in active TB patients. Such suppressive factors16,17 
may be released both by the host as well as the 
pathogen - M. tuberculosis during the active stage 
of the disease. Such factors may not be produced in 
cured patients, which in turn may be associated with 
increased lymphocyte response to M. tuberculosis. 
The present study suggests that DRBl *1501 
allele either alone or with DRBl *1502 or HLA- 
DR2 as a whole along with other HLA or non-HLA 
genes may be associated with the susceptibility to 
tuberculosis and regulate the immune responses in 
pulmonary tuberculosis irrespective of the disease 
status. 
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